Stryker Corp (SYK) stock analysis and fair value
SYK · NYSE · Healthcare
304,41 US$
▲ +2,17%
Cerne score
62out of 100
Fair
- Quality81
- Growth75
- Financial strength66
- Valuation33
- Dividends75
In 30 seconds
The business. Healthcare. Sells 25,1 B US$ a year, keeps 13% as profit and sales grow 11,8% a year (last 5 years).
Strength. Passes 5 of 8 quality checks, but debt weighs: 3,5 years of profit.
SYK fair value
Work out what the stock is worth with your own growth, margin and return assumptions. Free during launch.
See the fair valueStryker Corp key numbers
- Market cap
- 116,7 B US$
- P/E (price ÷ earnings)
- 36,2
- Dividend yield
- 1,09%
- Revenue growth
- 9,3%
- a year, over 9 years
- Profit margin
- 12,9%
- Quality checks
- 5/8
Fiscal 2025 financials, as filed with the SEC.
What analysts say
Buy
27 of 33 analysts recommend buying.
See everything about SYK on Cerne
- Fair value with your own assumptions
- Every analyst and price target
- 10 years of financials in simple charts
- Dividends, earnings and ratios vs. the sector